Cargando…
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receivin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547997/ https://www.ncbi.nlm.nih.gov/pubmed/32030595 http://dx.doi.org/10.1007/s10488-020-01018-1 |
_version_ | 1783592535128539136 |
---|---|
author | Ruud, Torleif Drivenes, Karin Drake, Robert E. Haaland, Vegard Øksendal Landers, Matthew Stensrud, Bjørn Heiervang, Kristin S. Tanum, Lars Bond, Gary R. |
author_facet | Ruud, Torleif Drivenes, Karin Drake, Robert E. Haaland, Vegard Øksendal Landers, Matthew Stensrud, Bjørn Heiervang, Kristin S. Tanum, Lars Bond, Gary R. |
author_sort | Ruud, Torleif |
collection | PubMed |
description | The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information. Trial registration: ClinicalTrials.gov Identifier: NCT03271242. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10488-020-01018-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7547997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-75479972020-10-19 The Antipsychotic Medication Management Fidelity Scale: Psychometric properties Ruud, Torleif Drivenes, Karin Drake, Robert E. Haaland, Vegard Øksendal Landers, Matthew Stensrud, Bjørn Heiervang, Kristin S. Tanum, Lars Bond, Gary R. Adm Policy Ment Health Original Paper The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information. Trial registration: ClinicalTrials.gov Identifier: NCT03271242. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10488-020-01018-1) contains supplementary material, which is available to authorized users. Springer US 2020-02-06 2020 /pmc/articles/PMC7547997/ /pubmed/32030595 http://dx.doi.org/10.1007/s10488-020-01018-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Ruud, Torleif Drivenes, Karin Drake, Robert E. Haaland, Vegard Øksendal Landers, Matthew Stensrud, Bjørn Heiervang, Kristin S. Tanum, Lars Bond, Gary R. The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title | The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title_full | The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title_fullStr | The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title_full_unstemmed | The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title_short | The Antipsychotic Medication Management Fidelity Scale: Psychometric properties |
title_sort | antipsychotic medication management fidelity scale: psychometric properties |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547997/ https://www.ncbi.nlm.nih.gov/pubmed/32030595 http://dx.doi.org/10.1007/s10488-020-01018-1 |
work_keys_str_mv | AT ruudtorleif theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT driveneskarin theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT drakeroberte theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT haalandvegardøksendal theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT landersmatthew theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT stensrudbjørn theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT heiervangkristins theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT tanumlars theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT bondgaryr theantipsychoticmedicationmanagementfidelityscalepsychometricproperties AT ruudtorleif antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT driveneskarin antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT drakeroberte antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT haalandvegardøksendal antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT landersmatthew antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT stensrudbjørn antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT heiervangkristins antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT tanumlars antipsychoticmedicationmanagementfidelityscalepsychometricproperties AT bondgaryr antipsychoticmedicationmanagementfidelityscalepsychometricproperties |